Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
25. Castera L, Vergniol J, Foucher J, Le Bail B, Chanteloup E, Haaser M, et al. Prospective<br />
comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the<br />
assessment of fibrosis in chronic hepatitis C. Gastroenterology 2005;128:343-350.<br />
26. Castera L, Le Bail B, Roudot-Thoraval F, Bernard PH, Foucher J, Merrouche W, et al.<br />
Early detection in routine clinical practice of cirrhosis and oesophageal varices in chronic<br />
hepatitis C: comparison of transient elastography (FibroScan) with standard laboratory<br />
tests and non-invasive scores. J Hepatol 2009;50(1):59-68.<br />
27. Chang PE, Lui HF, Chau YP, Lim KH, Yap WM, Tan CK, et al. Prospective evaluation of<br />
transient elastography for the diagnosis of hepatic fibrosis in Asians: comparison with<br />
liver biopsy and aspartate transaminase plate<strong>le</strong>t ratio index. Aliment Pharmacol Ther<br />
2008;28(1):51-61.<br />
28. Poynard T, Munteanu M, Imbert-Bismut F, Charlotte F, Thabut D, Le Calvez S, et al.<br />
Prospective analysis of discordant results between biochemical markers and biopsy in<br />
patients with chronic hepatitis C. Clin Chem 2004;50(8):1344-55.<br />
29. Sulkowski MS. Drug-induced liver injury associated with antiretroviral therapy that<br />
includes HIV-1 protease inhibitors. Clin Infect Dis 2004;38 Suppl 2:S90-7.<br />
30. Bani-Sadr F, Miailhes P, Rosenthal E, Yazdanpanah Y, Boyer L, Zucman D, et al. Risk<br />
factors for grade 3 or 4 gamma-glutamyl transferase e<strong>le</strong>vation in HIV/hepatitis C viruscoinfected<br />
patients. Aids 2008;22(10):1234-6.<br />
31. Ryan P, Blanco F, Garcia-Gasco P, Garcia-Merchan J, Vispo E, Barreiro P, et al.<br />
Predictors of severe hepatic steatosis using abdominal ultrasound in HIV-infected<br />
patients. HIV Med 2009;10(1):53-9.<br />
32. Shikuma CM, Day LJ, Gerschenson M. Insulin resistance in the HIV-infected population:<br />
the potential ro<strong>le</strong> of mitochondrial dysfunction. Curr Drug Targets Infect Disord<br />
2005;5(3):255-62.<br />
33. Guaraldi G, Squillace N, Stentarelli C, Orlando G, D'Amico R, Ligabue G, et al.<br />
Nonalcoholic fatty liver disease in HIV-infected patients referred to a metabolic clinic:<br />
preva<strong>le</strong>nce, characteristics, and predictors. Clin Infect Dis 2008;47(2):250-7.<br />
34. Castera L, Forns X, Alberti A. Non-invasive evaluation of liver fibrosis using transient<br />
elastography. J Hepatol 2008;48(5):835-47.<br />
35. Kettaneh A, Marcellin P, Douvin C, Poupon R, Ziol M, Beaugrand M, et al. Features<br />
associated with success rate and performance of FibroScan measurements for the<br />
diagnosis of cirrhosis in HCV patients: a prospective study of 935 patients. J Hepatol<br />
2007;46(4):628-34.<br />
36. Lucidarme D, Foucher J, Le Bail B, Vergniol J, Castera L, Duburque C, et al. Factors of<br />
accuracy of transient elastography (fibroscan) for the diagnosis of liver fibrosis in chronic<br />
hepatitis C. Hepatology 2009;49(4):1083-9.<br />
22
Change language